Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

ReShape Lifesciences Inc. (RSLS) had Revenue of $1.80M for the most recently reported fiscal quarter, ending 2024-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2024-12-31

Income Statement Financials
Revenue	$1.80M
Net Income	$-1.76M
Cost of Goods Sold	$0.49M
Gross Profit	$1.32M
Operating Expenses	$3.51M
Operating Income	$-1.70M
Non-Operating Income/Expense	$-0.05M
Pre-Tax Income	$-1.76M
Normalized Pre-Tax Income	$-1.76M
Income after Taxes	$-1.76M
Income from Continuous Operations	$-1.76M
Consolidated Net Income/Loss	$-1.76M
Normalized Income after Taxes	$-1.76M
EBIT	$-1.70M
EBITDA	$-1.59M
Weighted-Average Shares Outstanding (Basic)	0.02M
Weighted-Average Shares Outstanding (Diluted)	0.02M
Earnings per Share (EPS) (Basic)	$-49.98
Earnings per Share (EPS) (Diluted)	$-49.98
Balance Sheet Financials
Current Assets	$4.59M
Property, Plant, and Equipment	$0.04M
Long-Term Assets	$0.20M
Total Assets	$4.79M
Current Liabilities	$4.99M
Long-Term Debt	--
Long-Term Liabilities	$0.06M
Total Liabilities	$5.05M
Common Equity	$-0.25M
Tangible Shareholders Equity	$-0.25M
Shareholders Equity	$-0.25M
Common Shares Outstanding	0.03M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-4.43M
Cash Flow from Investing Activities	--
Cash Flow from Financial Activities	$0.68M
Beginning Cash	$4.56M
End Cash	$0.79M
Increase/Decrease in Cash	$-3.77M
Stock-Based Compensation	$0.18M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.92
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	-3.21
Gross Margin	73.07%
Operating Margin	-94.35%
EBIT Margin	-94.35%
EBITDA Margin	--
Pre-Tax Profit Margin	-97.34%
Profit Margin	-97.56%
Free Cash Flow	$-4.43M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.38
Inventory Turnover	0.20
Receiveable Turnover	1.83
Days Sales in Receivables	49.21
Return on Equity	696.08%
Return on Tangible Equity	696.05%
Return on Assets	-36.74%
Return on Investments	696.05%
Book Value Per Share	$-8.66
Free Cash Flow per Share	$-214.49
Operating Cash Flow per Share	$-214.49

Data from Zacks Investment Research, Inc.